|
Sign In to gain access to subscriptions and/or personal tools.
|
Comparison of Monotherapy Versus Combination Antihypertensive Therapy in Elderly Patients With Essential Hypertension
Stavros Antonopoulos, MD, PhD,
Stelios Kokkoris, MD,
Styliani Gerakari, MD,
Sotirios Mikros, MD,
Thomas Nitsotolis, MD,
Despina Vikeli, MD,
Panagiotis Korantzopoulos, MD, PhD*,
and
Gregory Giannoulis, MD, PhD
General Hospital of Ioannina
* To whom correspondence should be addressed. E-mail: p.korantzopoulos{at}yahoo.gr.
 |
Abstract |
|---|
Authors sought to compare the efficacy of monotherapy versus combination antihypertensive therapy in elderly patients. Patients in this study, aged 65 to 85 years, were divided into 4 groups and entered an 8-week treatment period. First group: 22 patients, amlodipine 5 mg/d increasing to 10 mg; second: 20 patients, eprosartan 600 mg/d increasing to 600 mg twice a day; third: 21 patients, amlodipine 5 mg/d and indapamide 2.5 mg/d, increasing amlodipine to 10 mg/d; fourth: 23 patients, imidapril 10 mg/d and indapamide 2.5 mg/d, imidapril doubled to 20 mg/d. A greater drop in systolic and in diastolic blood pressure was obtained by combination of amlodipine and indapamide compared with amlodipine or eprosartan monotherapy. Imidapril and indapamide showed similar efficacy compared with eprosartan monotherapy but not with amlodipine monotherapy. Amlodipine and indapamide appeared more effective than imidapril and indapamide in diastolic blood pressure. Combination treatment with amlodipine and indapamide or imidapril and indapamide effectively reduces blood pressure in elderly patients with essential hypertension.
First published on April 2, 2008, doi:10.1177/0003319707304580
Angiology 2008;59:230.
A more recent version of this article appeared on May 1, 2008
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
